535 related articles for article (PubMed ID: 29303069)
1. Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.
Ablasser K; Verheyen N; Glantschnig T; Agnetti G; Rainer PP
Curr Med Chem; 2019; 26(16):2865-2878. PubMed ID: 29303069
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Amyloidosis: Diagnosis and Treatment Strategies.
Tuzovic M; Yang EH; Baas AS; Depasquale EC; Deng MC; Cruz D; Vorobiof G
Curr Oncol Rep; 2017 Jul; 19(7):46. PubMed ID: 28528458
[TBL] [Abstract][Full Text] [Related]
3. The Ultrastructure of Tissue Damage by Amyloid Fibrils.
Koike H; Katsuno M
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361762
[TBL] [Abstract][Full Text] [Related]
4. Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.
Alkhawam H; Patel D; Nguyen J; Easaw SM; Al-Sadawi M; Syed U; Zaiem F; Homsi M; Vittorio TJ
Acta Cardiol; 2017 Aug; 72(4):380-389. PubMed ID: 28705053
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Amyloidosis Treatment.
Stern LK; Patel J
Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
[TBL] [Abstract][Full Text] [Related]
6. Targeted treatments of AL and ATTR amyloidosis.
Chandrashekar P; Desai AK; Trachtenberg BH
Heart Fail Rev; 2022 Sep; 27(5):1587-1603. PubMed ID: 34783948
[TBL] [Abstract][Full Text] [Related]
7. Cardiac amyloidosis.
Quarta CC; Kruger JL; Falk RH
Circulation; 2012 Sep; 126(12):e178-82. PubMed ID: 22988049
[No Abstract] [Full Text] [Related]
8. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
Fontana M; Ćorović A; Scully P; Moon JC
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
[TBL] [Abstract][Full Text] [Related]
10. Emerging Advances in the Management of Cardiac Amyloidosis.
Vranian MN; Sperry BW; Valent J; Hanna M
Curr Cardiol Rep; 2015 Nov; 17(11):100. PubMed ID: 26374453
[TBL] [Abstract][Full Text] [Related]
11. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.
Siddiqi OK; Ruberg FL
Trends Cardiovasc Med; 2018 Jan; 28(1):10-21. PubMed ID: 28739313
[TBL] [Abstract][Full Text] [Related]
12. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
[TBL] [Abstract][Full Text] [Related]
13. Emerging treatments for amyloidosis.
Sayed RH; Hawkins PN; Lachmann HJ
Kidney Int; 2015 Mar; 87(3):516-26. PubMed ID: 25469850
[TBL] [Abstract][Full Text] [Related]
14. Neuropathy Associated with Systemic Amyloidosis.
Kaku M; Berk JL
Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
[TBL] [Abstract][Full Text] [Related]
15. Advances in pharmacotherapy for cardiac amyloidosis.
Spoladore R; Falasconi G; Marcatti M; Di Maio S; Fiore G; Slavich M; Margonato A; Turco A; Fragasso G
Expert Opin Pharmacother; 2021 Mar; 22(4):469-481. PubMed ID: 33043721
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cardiac transthyretin amyloidosis: an update.
Emdin M; Aimo A; Rapezzi C; Fontana M; Perfetto F; Seferović PM; Barison A; Castiglione V; Vergaro G; Giannoni A; Passino C; Merlini G
Eur Heart J; 2019 Dec; 40(45):3699-3706. PubMed ID: 31111153
[TBL] [Abstract][Full Text] [Related]
19. Novel pharmacotherapies for cardiac amyloidosis.
Alexander KM; Singh A; Falk RH
Pharmacol Ther; 2017 Dec; 180():129-138. PubMed ID: 28648829
[TBL] [Abstract][Full Text] [Related]
20. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.
Izumiya Y; Hayashi H; Ishikawa H; Shibata A; Yoshiyama M
Intern Med; 2021 Jan; 60(1):1-7. PubMed ID: 32713926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]